Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eurand’s allergy pill performs well in study
Cetirizine is a leading prescription antihistamine sold in the US and other markets as Zyrtec by Pfizer. The AdvaTab version of the pill is a taste-masked, stabilized formulation
Cetirizine is a leading prescription antihistamine sold in the US and other markets as Zyrtec by Pfizer. The AdvaTab version of the pill is a taste-masked, stabilized formulation
Denavir (penciclovir cream) 1% is a topical antiviral prescription medication indicated for the treatment of herpes labialis, also known as cold sores, in adults. This is the only
Cerexa initiated a phase II trial of PPI-0903 for the treatment of complicated skin and skin structure infections (cSSSI) in October 2005. The fast track designation should help
In the trial, Corautus uses Boston Scientific’s Stiletto endocardial direct injection catheter system to deliver its investigational VEGF-2 biologic. To date, Corautus has treated 295 of the 404
Chronic functional vomiting (CFV) is believed to be caused by the abnormal function of the muscles or nerves controlling the organs of the middle and upper gastrointestinal tract.
The antibody, dubbed Sphingomab, binds and neutralizes sphingosine-1-phosphate (S1P), a member of a special class of lipids called sphingolipids. The antibody hinders the growth of tumors by preventing
The commencement of the phase III clinical trial triggers a milestone payment of $10 million from Astellas Pharma, XenoPort’s partner for developing and commercializing XP13512 in Japan and
The therapeutic peptide – originally named TT-232 and now referred to as CAP-232 – was developed at Biostatin Pharmaceutical R&D of Budapest, Hungary. Biostatin characterized CAP-232’s mechanism of
The experimental drug is said to have caused a severe inflammatory reaction and multiple organ failure in some of the trial participants. The company that was developing the
Under the terms of the agreement, Argos will receive up to $69 million, comprised of upfront and milestone payments, in addition to royalties on potential future sales of